BRULX
Price
$17.90
Change
+$0.13 (+0.73%)
Updated
Jun 2 closing price
Net Assets
331.29M
RMFCX
Price
$62.47
Change
+$0.39 (+0.63%)
Updated
Jun 2 closing price
Net Assets
114.65B
Interact to see
Advertisement

BRULX vs RMFCX

Header iconBRULX vs RMFCX Comparison
Open Charts BRULX vs RMFCXBanner chart's image
BRULX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
BRULX vs. RMFCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRULX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 115B vs. BRULX (331M). RMFCX pays higher dividends than BRULX: RMFCX (1.19) vs BRULX (1.08). BRULX was incepted earlier than RMFCX: BRULX (11 years) vs RMFCX (24 years). RMFCX (0.91) is less costly to investors than BRULX (0.69). BRULX is a more actively managed with annual turnover of: 48.00 vs. RMFCX (30.00). BRULX has a lower initial minimum investment than RMFCX: BRULX (0) vs RMFCX (250). BRULX annual gain was more profitable for investors over the last year : 14.56 vs. RMFCX (10.10). RMFCX return over 5 years is better than : 33.85 vs. BRULX (14.89).
BRULXRMFCXBRULX / RMFCX
Total Expense Ratio0.640.9170%
Annual Report Gross Expense Ratio0.690.9176%
Fund Existence11 years24 years-
Gain YTD13.6925.845234%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets331M115B0%
Annual Yield % from dividends1.081.1991%
Returns for 1 year14.5610.10144%
Returns for 3 years34.9934.65101%
Returns for 5 years14.8933.8544%
Returns for 10 years91.3891.46100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVCO12.161.49
+13.96%
Silvaco Group Inc
ZG36.580.14
+0.38%
Zillow Group
ORIQU10.30N/A
N/A
Origin Investment Corp I
YHNA10.86N/A
N/A
YHN Acquisition I Ltd
TSHA5.67-0.30
-5.03%
Taysha Gene Therapies